Mode
Text Size
Log in / Sign up

Mycoplasma pneumoniae pneumonia

Part of Pneumonia

10 published articles · Updated continuously

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.

Research across Pneumonia

Related studies from across the Pneumonia family.

Autoantibody positivity and false-negative cytology can mask invasive mucinous adenocarcinoma in patients with IPAF
Allergy & Immunology Sys. Review
Autoantibody positivity and false-negative cytology can mask invasive mucinous adenocarcinoma in patients with IPAF Lung cancer can mimic autoimmune lung disease in some patients
This case report describes a 78-year-old female with invasive mucinous adenocarcinoma and interstitial pneumonia with autoimmune features. T…
A new case shows how a rare lung cancer can look like an autoimmune disease, making it hard for doctors to tell them apart.
MRSA nares PCR does not cut vancomycin duration in ICU CAP
Infectious Disease RCT
MRSA nares PCR does not cut vancomycin duration in ICU CAP MRSA Testing Does Not Reduce Vancomycin Use in Pneumonia Patients
In a single-center randomized trial of 277 adult ICU patients with suspected community-acquired pneumonia, MRSA nares PCR testing did not si…
A trial of 277 ICU patients found that MRSA nasal swab testing did not reduce the amount of vancomycin used for pneumonia.
Physical frailty tops risk factors for pneumonia after esophagectomy, meta-analysis finds
Geriatrics & Aging Meta-analysis
Physical frailty tops risk factors for pneumonia after esophagectomy, meta-analysis finds Physical frailty and muscle loss increase pneumonia risk after surgery
This meta-analysis of 60 cohort studies in esophageal cancer patients undergoing esophagectomy identified physical frailty as the highest-ra…
Patients with esophageal cancer face a higher risk of pneumonia after surgery if they show signs of physical frailty or muscle loss.
Short-course ceftriaxone reduces hospital stay and adverse events in children with pneumonia
Infectious Disease RCT
Short-course ceftriaxone reduces hospital stay and adverse events in children with pneumonia Shorter antibiotic courses may help children with pneumonia stay home
This randomized controlled trial of 200 children aged 1 to 14 years found that short-course ceftriaxone (5 to 7 days) resulted in shorter ho…
A new trial shows that a shorter course of ceftriaxone can reduce hospital stays and side effects for children with pneumonia.
Aerosolized liposomal amphotericin B provides strongest evidence for invasive pulmonary aspergillosis prophylaxis in high-risk patients
Gastroenterology Sys. Review
Aerosolized liposomal amphotericin B provides strongest evidence for invasive pulmonary aspergillosis prophylaxis in high-risk patients Aerosolized Amphotericin B Shows Promise for Lung Fungal Infections
This mini review synthesizes clinical experience regarding aerosolized antifungal therapies for various pulmonary fungal infections. It conc…
Aerosolized liposomal amphotericin B shows promise for preventing specific lung fungal infections in high-risk and immunocompromised patient…
mNGS achieves 85.83% pathogen detection rate in children with severe pneumonia compared to 49.97% for conventional methods
Pediatrics Sys. Review
mNGS achieves 85.83% pathogen detection rate in children with severe pneumonia compared to 49.97% for conventional methods New Genetic Test Finds More Pneumonia Germs in Kids
This systematic review evaluates metagenomic next-generation sequencing (mNGS) for identifying pathogens in children with severe pneumonia. …
A new genetic test detects pneumonia-causing germs in kids more often than standard methods, which could lead to better treatment.
Inhaled antibiotics may improve lung function and microbiological eradication in cystic fibrosis and bronchiectasis
Infectious Disease Meta-analysis
Inhaled antibiotics may improve lung function and microbiological eradication in cystic fibrosis and bronchiectasis Inhaled Antibiotics May Improve Lung Health in Chronic Lung Conditions
This meta-analysis evaluated the efficacy of inhaled antibiotics for patients with cystic fibrosis, non-cystic fibrosis bronchiectasis, and …
Inhaled antibiotics may improve lung function and clear infections for people with cystic fibrosis and other chronic lung conditions.
Antibiotic exposure disrupts gut microbiota in 58% to 94% of critically ill children
Infectious Disease Sys. Review
Antibiotic exposure disrupts gut microbiota in 58% to 94% of critically ill children Antibiotics and gut health in critically ill children
This narrative review examines antibiotic exposure in critically ill children in the PICU, reporting that 58% to 94% receive antibiotics, wh…
Common antibiotics used in intensive care can disrupt a child's gut health, increasing the risk of serious infections like pneumonia.
iNKT cell activators show promise in preclinical models for stroke-associated pneumonia immunomodulation
Pulmonology & Critical Care Meta-analysis
iNKT cell activators show promise in preclinical models for stroke-associated pneumonia immunomodulation New immune treatments show promise for stroke and pneumonia
This systematic review of 38 preclinical studies examines the immunopathology of stroke-associated pneumonia (SAP) and the role of immunomod…
Researchers identify how stroke triggers immune failure and find a promising new way to protect the lungs from pneumonia infections.
IL-6 overexpression linked to alveolar damage in severe pneumonia on ventilation
Primary Care & Family Medicine Sys. Review
IL-6 overexpression linked to alveolar damage in severe pneumonia on ventilation IL-6 Levels Linked to Lung Damage in Severe Pneumonia
This narrative review synthesizes basic and clinical evidence on IL-6 in mechanically ventilated patients with severe pneumonia. It finds th…
High levels of a protein called IL-6 may be linked to increased lung damage and inflammation in patients with severe pneumonia.
Low-dose corticosteroids reduce 90-day mortality in adults with severe community-acquired pneumonia
Pulmonology & Critical Care Meta-analysis
Low-dose corticosteroids reduce 90-day mortality in adults with severe community-acquired pneumonia Low dose steroids may lower death rates in severe lung infections
This meta-analysis of 4,622 patients found that low-dose corticosteroids (≤400 mg hydrocortisone-equivalent daily) significantly reduced sho…
A review of clinical trials suggests that low-dose corticosteroids can reduce 90-day mortality for adults with severe lung infections like p…
Oral amoxicillin or amoxicillin-clavulanate is non-inferior to intravenous treatment for severe CAP in children
Pediatrics RCT
Oral amoxicillin or amoxicillin-clavulanate is non-inferior to intravenous treatment for severe CAP in children Trial shows oral antibiotics work for children with severe pneumonia
This randomized controlled trial of 1,101 children with severe community-acquired pneumonia in sub-Saharan Africa found that step-down oral …
A large trial in Africa found that switching children from IV to oral antibiotics for pneumonia is as safe and effective as staying on IV tr…

Questions about Mycoplasma pneumoniae pneumonia

Does having pleural effusion increase the risk of refractory Mycoplasma pneumoniae pneumonia?

Yes, multiple studies and meta-analyses consistently identify pleural effusion as an independent risk factor for refractory Mycoplasma pneumoniae pneumonia in children.

Full answer →
What clinical indicators predict refractory Mycoplasma pneumoniae pneumonia in children?

Doctors can predict refractory Mycoplasma pneumoniae pneumonia in children using specific signs like long fever duration, lung complications like pleural effusion, and high levels of inflammatory markers like CRP and LDH.

Full answer →
Is an atopic constitution linked to severe Mycoplasma pneumoniae pneumonia in children?

Yes, atopic constitution is linked to severe Mycoplasma pneumoniae pneumonia in children, with 74.8% of affected children having atopy and 7.1% progressing to severe disease.

Full answer →
Can a case report explain necrotizing laryngotracheobronchitis after Mycoplasma pneumoniae pneumonia?

Yes, a case report can describe necrotizing laryngotracheobronchitis after Mycoplasma pneumoniae pneumonia, as shown in a detailed case of a 7-year-old boy.

Full answer →
What clinical indicators predict refractory Mycoplasma pneumoniae pneumonia in children?

Key predictors of refractory Mycoplasma pneumoniae pneumonia in children include prolonged fever, high CRP, high neutrophil-to-lymphocyte ratio, pleural effusion, atelectasis, and extrapulmonary complications.

Full answer →
Can switching from azithromycin to doxycycline help children with Mycoplasma pneumoniae pneumonia?

Yes, switching from azithromycin to doxycycline can help children with Mycoplasma pneumoniae pneumonia, especially when macrolide resistance is suspected or the child does not improve after 72 hours of azithromycin.

Full answer →
See all 6 questions about Mycoplasma pneumoniae pneumonia →